What's new

Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised

Mar 27, 2025 - 16:45
 0
Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): Cresemba, isavuconazole, Date of authorisation: 15/10/2015, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Febuxostat Krka, febux...

Next Article

The Weekly Sip: Suntory takes Jim Beam to the tropics | Molson Coors shakes up f...

Related Posts

Human medicines European public assessment report (EPAR): Nimenrix, meningococcal groups A, C, W-135 and Y conjugate vaccine, Date of authorisation: 20/04/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Human medicines European public assessment report (EPAR): Skytrofa (previously Lonapegsomatropin Ascendis Pharma), lonapegsomatropin, Date of authorisation: 11/01/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

Veterinary product information (QRD) templates

Veterinary product information (QRD) templates

Mar 10, 2025  0